William Benton Jones

Insider Reports History

Entity
Individual
Location
863 Mitten Road, Suite 102, Burlingame, CA
Signature
/s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Benton Jones:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Corvus Pharmaceuticals, Inc. SVP, Pharmaceutical Development Common Stock 154K $266K $1.73 May 6, 2024 Direct
Corvus Pharmaceuticals, Inc. SVP, Pharmaceutical Development Stock Option (Right to Buy) 300K Dec 20, 2024 Direct
Corvus Pharmaceuticals, Inc. SVP, Pharmaceutical Development Warrant (Right to Buy) 19.4K May 6, 2024 Direct

Insider Reports Filed by William Benton Jones

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRVS Corvus Pharmaceuticals, Inc. Dec 20, 2024 1 $0 4 Dec 23, 2024 SVP, Pharmaceutical Development
CRVS Corvus Pharmaceuticals, Inc. May 6, 2024 2 $34.6K 4 May 7, 2024 SVP, Pharmaceutical Development
CRVS Corvus Pharmaceuticals, Inc. Dec 6, 2023 1 $0 4 Dec 8, 2023 SVP, Pharmaceutical Development
CRVS Corvus Pharmaceuticals, Inc. Dec 20, 2022 1 $15.8K 4 Dec 20, 2022 SVP, Pharmaceutical Development
CRVS Corvus Pharmaceuticals, Inc. Aug 11, 2022 1 $0 4 Aug 15, 2022 SVP, Pharmaceutical Development
CRVS Corvus Pharmaceuticals, Inc. Sep 9, 2021 1 $0 4 Sep 13, 2021 SVP, Pharmaceutical Development